Thermo Fisher buys research firm PPD for $ 17.4 billion


THermo Fisher Scientific announced Thursday that it will acquire PPD, a contract research firm for the pharmaceutical and biotech industries, in a deal valued at $ 17.4 billion, plus support for around 3 , $ 5 billion in debt.

The acquisition will allow Thermo Scientific, a leader in Waltham-based laboratory equipment and services, to expand its reach into the life sciences. PPD, based in North Carolina, provides services to help pharmaceutical companies conduct clinical trials.

Unlock this article by subscribing to STAT + and enjoy your first 30 days free!


What is that?

STAT + is STAT’s premium subscription service for in-depth coverage and analysis of biotechnology, pharmaceuticals, policy and life sciences. Our award-winning team covers the news on Wall Street, policy developments in Washington, early scientific breakthroughs and clinical trial results, as well as healthcare disruptions in Silicon Valley and beyond.

What is included?

  • Daily reporting and analysis
  • Industry’s most comprehensive coverage from a powerful team of journalists
  • Newsletters reserved for subscribers
  • Daily newsletters to keep you informed of the most important industry news of the day
  • STAT + conversations
  • Weekly opportunities to engage with our journalists and leading industry experts in live video chats
  • Exclusive industry events
  • Premium access to subscriber-only networking events nationwide
  • The best reporters in the industry
  • The most reliable and most connected newsroom in the healthcare industry
  • And much more
  • Exclusive interviews with industry leaders, profiles and premium tools, like our CRISPR Trackr.


Leave A Reply